February 5, 2021 – UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, has announced the pricing of its initial public offering…Read More
“I was so pleased to work with FLG Partners at Institute for the Future. Frank Tsai, the partner we used from FLG, is the best nonprofit finance executive and advisor that I have come across in my 20 years in the NFP world. Frank is strategic, fast (had a rapid understanding of our business) and organized (think high value). He can quickly access what is important and what’s not. Finally, Frank brings years of experience to the table from working with a variety of nonprofits of different scales and configurations. He understands everything from strategy and modeling down to the detailed work of NFP accounting, compliance, taxes, audits, legal, and NFP protocols and standards. I wouldn’t hesitate to work with Frank (and FLG) again.”
Jean Hagan, Executive Producer, Institute for the Future Read More